Morningstar Investor users sign in here.
TOPIC

BIO News & Analysis

Cochlear shrugs off slump with new tech trial
Stocks
Cochlear shrugs off slump with new tech trial
Biotech stock Cochlear has kicked off the next phase of implant technology as the healthcare sector takes a tumble.
Emma Rapaport | 10 October 2018